Cheiron raises $8M to build an operating system for drug programs
Menlo Ventures is backing the Stanford-linked founders' move from biopharma search into clinical, regulatory and program decision software.
By Ryan Merket · Published
Primary source: GlobeNewswire
Why it matters
Cheiron is using a seed round to move from sourced biopharma answers into software that tracks decisions across entire drug programs, a broader market with higher regulatory and integration demands.
Minseok Bae, Jason Park and Harshit Gupta have raised an $8 million seed round for Cheiron, giving the young Stanford-linked founding group fresh capital to turn a biopharma research assistant into a system of record for drug development.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.